We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Private treatment

20 July 2021 By Aimee Donnellan

Investors in hospital operator Spire blocked a $1.4 bln takeover by an Australian rival, in the latest sign of pushback to takeovers. Yet reaching a similar value on its own looks tricky given lingering virus effects. Tensions with rebel shareholders are an added complication.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)